Author:
Isnard-Bagnis Corinne,Deray Gilbert
Reference202 articles.
1. Safirstein RL. Anticancer drugs. In: Clinical Nephrotoxins. De Broe ME, Porter GA, Bennett WM, Verpooten GA (editors). Kluwer Academic Publ, Dordrecht 1998; p. 261–271.
2. Meijer S, Mulder NH, Sleijfer DT, de Jong PE, Sluiter WJ, Schraffordt Koops H, van der Hem GK. Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of the testicular carcinoma. Cancer Chemother Pharmacol 1982; 8: 27–30.
3. Brock PR, Koliouska DE, Baratt TM, Yeomans E, Pritchard J. Partial reversibility of cisplatin nephrotox-icity in children. J Pediatric 1991; 118: 531–534.
4. Yuhas JM, Culo F. Selective inhibition of the nephrotoxicity of cis-dichlorodiamine platinum by WR 272l without altering its antitumor properties. Cancer Treat Rep 1980; 64: 57–64.
5. Borch RF, Pleasants ME. Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat renal model. Proc Natl Acad Sci USA 1979; 76: 6611–6614.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献